SEC Form 4 · accession 0001041889-15-000002
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James V. Dyke
Officer — Vice President - Sales
Period of report
Apr 29, 2015
Accepted (ET)
May 1, 2015 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.005 Par ValueF1 | Apr 29, 2015 | A | 6,500 | $0.00 | A | 42,064 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 25% of the shares on April 29, 2016 and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient is in the continuous employ of the Issuer through each such respective vesting date.